» Articles » PMID: 35023036

Phenotyping OSAH Patients During Wakefulness

Overview
Journal Sleep Breath
Publisher Springer
Date 2022 Jan 13
PMID 35023036
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Although currently there are simplified methods to measure the pathophysiological traits that stimulate the occurrence and maintenance of obstructive sleep apnea-hypopnea (OSAH), they remain difficult to implement in routine practice. This pilot study aimed to find a simpler daytime approach to obtain a meaningful, similar pathophysiological phenotypic profile in patients with OSAH.

Methods: After obtaining diagnostic polygraphy from a group of consecutive patients with OSAH, we performed the dial-down CPAP technique during nocturnal polysomnography and used it as reference method. This allowed assessment of upper airway collapsibility, loop gain (LG), arousal threshold (AT), and upper airway muscle gain (UAG). We compared these results with a daytime protocol based on negative expiratory pressure (NEP) technique for evaluating upper airway collapsibility and UAG, on maximal voluntary apnea for LG, and on clinical predictors for AT.

Results: Of 15 patients studied, 13 patients with OSAH accurately completed the two procedures. There were strong (all r > 0.75) and significant (all p < 0.001) correlations for each phenotypic trait between the measurements obtained through the reference method and those achieved during wakefulness.

Conclusion: It is possible to phenotype patients with OSAH from a pathophysiological point of view while they are awake. Using this approach, cutoff values corresponding to those usually adopted using the reference method can be identified to detect abnormal traits, achieving profiles similar to those obtained through the dial-down CPAP technique.

Citing Articles

Relationship between airflow limitation in response to upper airway negative pressure during wakefulness and obstructive sleep apnea severity.

Lim J, Alshaer H, Montazeri Ghahjaverestan N, Bradley T Sleep Breath. 2023; 28(1):231-239.

PMID: 37548919 DOI: 10.1007/s11325-023-02892-3.


Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation.

Perger E, Castiglioni P, Faini A, Soranna D, Zambon A, Rosa D Sci Rep. 2023; 13(1):3178.

PMID: 36823241 PMC: 9950422. DOI: 10.1038/s41598-023-29436-9.


Obstructive Sleep Apnea and Adherence to Continuous Positive Airway Pressure (CPAP) Treatment: Let's Talk about Partners!.

Rosa D, Amigoni C, Rimoldi E, Ripa P, Ligorio A, Fracchiolla M Healthcare (Basel). 2022; 10(5).

PMID: 35628081 PMC: 9141202. DOI: 10.3390/healthcare10050943.

References
1.
Martinez-Garcia M, Campos-Rodriguez F, Barbe F, Gozal D, Agusti A . Precision medicine in obstructive sleep apnoea. Lancet Respir Med. 2019; 7(5):456-464. DOI: 10.1016/S2213-2600(19)30044-X. View

2.
Uccelli S, Pini L, Bottone D, Ranieri P, Orzes N, Tantucci C . Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation. Int J Chron Obstruct Pulmon Dis. 2020; 15:2549-2558. PMC: 7584515. DOI: 10.2147/COPD.S269346. View

3.
Taranto-Montemurro L, Messineo L, Perger E, Salameh M, Pini L, Corda L . Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea. COPD. 2016; 13(6):706-711. DOI: 10.1080/15412555.2016.1199668. View

4.
Quadri F, Boni E, Pini L, Bottone D, Venturoli N, Corda L . Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement. Respir Physiol Neurobiol. 2016; 236:51-56. DOI: 10.1016/j.resp.2016.11.004. View

5.
Malhotra A, Mesarwi O, Pepin J, Owens R . Endotypes and phenotypes in obstructive sleep apnea. Curr Opin Pulm Med. 2020; 26(6):609-614. PMC: 7544644. DOI: 10.1097/MCP.0000000000000724. View